Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422407 · ClinicalTrials.gov registry record
A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome
A clinical trial of Healthy and Sjögren's Syndrome, sponsored by Biogen.
- Completed
- Registry status
- 100
- Enrollment target
- 4
- Study locations
NCT02422407: Completed study of Healthy and Sjögren's Syndrome, sponsored by Biogen.
NCT02422407 is a study of Healthy and Sjögren's Syndrome that has completed, run by Biogen. The registered enrollment target is 100 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (85% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02422407, a study of Healthy and Sjögren's Syndrome, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
The main objective of the study is to characterize the gene expression in immune and epithelial cells in salivary gland biopsy samples and blood of pSS (primary Sjögren's syndrome) and non-pSS participants including healthy volunteers.
Conditions Studied
Interventions
- PROCEDURE Biopsy
Study Locations (4)
Connecticut
- Research Site - Hartford
Massachusetts
- Research Site - Boston
Pennsylvania
- Research Site - Philadelphia
Texas
- Research Site - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-03-26 |
| Est. Completion | 2017-08-22 |
What the finished NCT02422407 record still lists
NCT02422407 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (85% lower).
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Biopsy is the first listed.
NCT02422407 reports a single indexed study location in Connecticut, Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02422407 about?
NCT02422407 is a clinical study titled "A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome". The main objective of the study is to characterize the gene expression in immune and epithelial cells in salivary gland biopsy samples and blood of pSS (primary Sjögren's syndrome) and non-pSS participants including healthy volunteers.
What is the current status of trial NCT02422407?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-03-26. Estimated completion is 2017-08-22.
What conditions does trial NCT02422407 study?
This clinical trial studies the following conditions: Healthy, Sjögren's Syndrome, Sicca Syndrome.
What interventions are being tested in trial NCT02422407?
The interventions under investigation include: Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02422407?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02422407 being conducted?
This trial has 4 study locations across Connecticut, Massachusetts, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02422407's enrollment target sits among peer trials
100 219th of 1090 higher than 851 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI